HPV vaccination: little evidence for autoimmunity, neurological outcomes


Human papillomavirus (HPV) vaccination for young females has been promoted as an important public health initiative to reduce the risk of cervical cancer in later life. However, some have questioned whether HPV vaccination promotes autoimmunity. This issue is especially relevant for patients with pre-existing autoimmune disorders, who may be at increased risk of persistent HPV infection and cervical dysplasia (Feldman & Kim. Expert Rev Vaccines 2014; Jun 17:1-4).

It takes 30 seconds

Recommend to a Colleague Go back to home page